Treatments & Services

MGCD516 for Solid Tumor Malignancies

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Disease Types: Solid Tumors

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies